According to a recent report from Persistent Market Research, the global hematology analyzer and reagent market is expected to achieve an impressive growth rate during the period 2015-2021. The key users of hematology reagents and analyzers are clinical testing laboratories, hospitals, and research institutions.
Hematology systems are indispensable tools in clinical laboratories, assisting in the diagnosis of various diseases such as infections, anemia, viruses, diabetes, genetic problems, and cancer, and to regulate plasma drug level for both therapeutic and illicit drugs. Made up of multiple analytical modules with unique sample preparation processes, these highly specialized instruments count the number of white blood cells, red blood cells, and platelets in samples.
Some of the key factors that are fuelling the market's growth are:
- Increasing adoption of automated hematology instruments
- Rising technological advancements
- Integration of basic flow-cytometry techniques in modern hematology analyzers
- High-throughput hematology analyzers and
- Development of high-sensitivity point-of-care (POC) hematology testing
The report also lists the factors that impede the market growth: the high cost of hematology analyzers, intense competition among existing players, stringent and time-consuming regulatory policies for hematology instruments.
Due to the region's high disposable income and increasing adoption of automated hematology instruments by diagnostics laboratories, North America dominates the market, followed by Europe. However, Asia is expected to be the fastest growing market in the next five years due to factors such as developing healthcare infrastructure, increasing funding towards the development of hematology products, rising awareness about better healthcare and a large patient population base.
It is expected that the use of microfluidics technology in hematology analyzers, introduction of digital imaging system in hematology laboratories and increasing focus toward emerging markets such as India and China, could open up opportunities for new players in the global hematology analyzer and reagents market. One of the latest trends in the market is the increasing instances of partnership among hematology instruments and consumables manufacturers.
Key manufacturers operating in this market are Sysmex Corporation, Abbott Laboratories, Beckman Coulter Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Siemens Healthcare, HORIBA, Ltd. and NIHON KOHDEN CORPORATION.